Literature DB >> 9009282

Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.

K A Norris1, J E Schrimpf, M J Szabo.   

Abstract

Trypanosoma cruzi trypomastigotes are exquisitely resistant to the lytic effects of vertebrate complement, and this characteristic contributes to the survival of the parasites in the host bloodstream. Trypomastigotes avoid complement-mediated lysis by the production of a surface glycoprotein that inhibits the formation of the alternative and classical C3 convertase, thus preventing activation and amplification of the complement cascade at the parasite surface. We have developed a monoclonal antibody to the 160-kDa T. cruzi complement regulatory protein (CRP) and describe a one-step immunoaffinity purification procedure. The CRP was purified to homogeneity and subjected to amino-terminal peptide sequence analysis. Based on the protein sequence obtained, the CRP was identified as a member of a large family of trypomastigote-specific genes, and a complete cDNA was isolated and sequenced. The complete coding sequence was cloned in Escherichia coli, and antibodies raised against the full-length recombinant protein reacted specifically with a 160-kDa protein in trypomastigote membrane protein preparations as well as with native, purified CRP. Indirect immunofluorescence revealed that the protein is uniformly expressed at the cell surfaces of trypomastigotes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009282      PMCID: PMC174602          DOI: 10.1128/iai.65.2.349-357.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.

Authors:  G A Schmuñis; A Szarfman; T Langembach; W de Souza
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family.

Authors:  E E Jazin; E J Bontempi; D O Sanchez; L Aslund; J Henriksson; A C Frasch; U Pettersson
Journal:  Parasitology       Date:  1995-01       Impact factor: 3.234

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  Trypanosoma cruzi: antibody-induced mobility of surface antigens.

Authors:  G A Schmuñis; A Szarfman; W De Souza; T Langembach
Journal:  Exp Parasitol       Date:  1980-08       Impact factor: 2.011

5.  Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.

Authors:  M T Rimoldi; A Sher; S Heiny; A Lituchy; C H Hammer; K Joiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Identification of monoclonal antibodies against the trypomastigote stage of Trypanosoma cruzi by use of iminobiotinylated surface polypeptides.

Authors:  C A Beard; R A Wrightsman; J E Manning
Journal:  Mol Biochem Parasitol       Date:  1985-08       Impact factor: 1.759

7.  Role of complement in immune lysis of Trypanosoma cruzi.

Authors:  D F Anziano; A P Dalmasso; R Lelchuk; C Vásquez
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

8.  gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.

Authors:  E Fischer; M A Ouaissi; P Velge; J Cornette; M D Kazatchkine
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

9.  Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.

Authors:  T L Kipnis; J R David; C A Alper; A Sher; W D da Silva
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  21 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.

Authors:  K A Norris
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.

Authors:  P Sepulveda; M Hontebeyrie; P Liegeard; A Mascilli; K A Norris
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 4.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

5.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

6.  Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.

Authors:  M Beucher; K A Norris
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

7.  Golgi UDP-GlcNAc:polypeptide O-α-N-Acetyl-d-glucosaminyltransferase 2 (TcOGNT2) regulates trypomastigote production and function in Trypanosoma cruzi.

Authors:  Carolina M Koeller; Hanke van der Wel; Christa L Feasley; Fernanda Abreu; Juliana Dutra Barbosa da Rocha; Fabrício Montalvão; Patrícia Fampa; Flávia C G Dos Reis; Georgia C Atella; Thaís Souto-Padrón; Christopher M West; Norton Heise
Journal:  Eukaryot Cell       Date:  2014-08-01

8.  Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.

Authors:  Marianne A Bryan; Karen A Norris
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

10.  Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells.

Authors:  Daniela A Bermejo; Shaun W Jackson; Melisa Gorosito-Serran; Eva V Acosta-Rodriguez; Maria C Amezcua-Vesely; Blythe D Sather; Akhilesh K Singh; Socheath Khim; Juan Mucci; Denny Liggitt; Oscar Campetella; Mohamed Oukka; Adriana Gruppi; David J Rawlings
Journal:  Nat Immunol       Date:  2013-04-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.